Logo Image
Commentary|Podcasts|May 14, 2024

Healthcare Marketing Strategies for Reaching Diverse Audiences

Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.

Amanda Powers-Han, Chief Marketing Officer, Greater Than One discusses:

  • How improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes
  • Challenges healthcare marketers face in crafting culturally sensitive messages that resonate with diverse audiences and address their specific healthcare needs
  • Other tactics can healthcare marketers utilize to ensure their outreach goes beyond visuals to truly connect with diverse audiences on a deeper level
  • Their 501c3, Greater Good and it's arm, Honeycomb Health

Related to this article

View more
Pharmaceutical Executive Daily
Pharmaceutical Executive Daily: Nxera Licenses EP4 Agonist to AbbVie
How microgravity is opening new possibilities for drug R&D and manufacturing, a pharma funding roundup covers Boehringer Ingelheim’s up-to-$7 billion oncology licensing deal with Sino Biopharmaceutical and Nxera Pharma’s EP4 agonist deal with AbbVie, and CytoDyn’s Dr. Jay Lalezari on why Leronlimab isn’t just another repurposed drug.
Read more
Pharmaceutical Executive daily
Pharmaceutical Executive Daily: FDA Approves Voceryq
FDA grants accelerated approval to INOVIO’s Voceryq to reduce surgical burden in recurrent respiratory papillomatosis, Brox.AI’s Hamish Brocklebank on the three levels of digital clone use cases in pharma, and CytoDyn’s Dr. Jay Lalezari on his path from HIV clinician to CEO.
Read more